Bruce Binkowitz

Dr Binkowitz brings over 30 years of drug development experience. Prior to joining Arcutis, Dr. Binkowitz was the vice president of Biometrics at Shionogi, Inc., after spending over 30 years at Merck and Co. He has worked across all phases of drug development and across many therapeutic areas including dermatology, oncology, respiratory, metabolism/diabetes, cardiovascular, and ophthalmology. Dr. Binkowitz has presented at all the major statistics conferences and has publications spanning more than 30 years, including his contributions as a thought leader on the topic of multiregional clinical trials, which culminated in his being co-editor of the textbook “Simultaneous Global New Drug Development”. Dr. Binkowitz is a fellow of the American Statistical Association (ASA) and was the 2020 chair of the biopharmaceutical section of the ASA, and was selected for the 2022 Rutgers School of Public Health Distinguished Alumni Award. Dr. Binkowitz has a Ph.D. in quantitative methodology from the Rutgers School of Public Health, and a master’s degree in statistics from the University of Florida.